Real-world efficacy and safety of anlotinib as third- or further-line treatment in refractory small cell lung cancer

Xuetian Gao, Ling Peng, Li Zhang, Kai Huang, Cuihua Yi, Bei Li, Xue Meng, Jisheng Li

Journal of Cancer Research and Clinical Oncology · 2021 · 10 citations · 19 references

DOIFull text

Open access

Concepts

References

19